In 2015, it was expected that with first-time treatment options, the greater availability of low-cost drugs and better use of evidence to inform optimal decision-making, stakeholders around the world could expect more “bang for their medicine buck” in 2020 than ever before. Now that 2020 is almost tomorrow:
Find out in the first report of the new year from the IQVIA Institute. Launched on January 29, The Global Use of Medicine in 2019 and Outlook to 2023 offers insights and predictions about the global market, new launches, losses of exclusivity, biosimilars, specialty products and more. Discover the trends to keep an eye on, including the emergence and growing influence of biopharma companies in the late-stage pipeline and launches.